Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration-Reference-Cited by-同舟云学术

Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration

Published:2021-03-31 Issue:1 Volume:110 Page:210-219
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Le Tilly Olivier¹²,Azzopardi Nicolas³,Bonneau Claire⁴,Desvignes Céline¹⁵,Oberkampf Florence⁶,Ezzalfani Monia⁷,Ternant David¹²⁵,Turbiez Isabelle⁸,Gutierrez Maya⁶,Paintaud Gilles¹²⁵

Affiliation:

1. EA 4245 Transplantation, Immunologie, Inflammation Université de Tours Tours France

2. Department of Medical Pharmacology CHRU de Tours Tours France

3. EA 7501 Groupe Innovation et Ciblage Cellulaire Université de Tours Tours France

4. Department of Surgery Institut Curie Hôpital René Huguenin Saint Cloud France

5. Pilot Centre for Therapeutic Antibodies Monitoring (PiTAM) CHRU de Tours Tours France

6. Department of Oncology Institut Curie Hôpital René Huguenin Saint Cloud France

7. Biometry Unit Institut Curie PSL Research University Paris France

8. Department of Clinical Research Institut Curie Hôpital René Huguenin Saint Cloud France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2188

Reference32 articles.

1. Survival of breast cancer patients with meningeal carcinomatosis

2. Leptomeningeal disease and the evolving role of molecular targeted therapy and immunotherapy;Hall Thomas K.;Ochsner J.,2017

3. Neoplastic meningitis;Chamberlain M.C.;Neurol.,2006

4. Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy for leptomeningeal disease in breast cancer;Cancer Treatment Reviews;2024-01

2. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?;Expert Review of Neurotherapeutics;2023-12-25

3. Druggable genomic landscapes of high-grade gliomas;Frontiers in Medicine;2023-12-08

4. A Minimal PBPK Model for Plasma and Cerebrospinal Fluid Pharmacokinetics of Trastuzumab after Intracerebroventricular Administration in Patients with HER2-Positive Brain Metastatic Localizations;Pharmaceutical Research;2023-10-11

5. A Minimal PBPK Model for Plasma and Cerebrospinal Fluid Pharmacokinetics of Trastuzumab after Intracerebroventricular Administration in Patients with HER2-Positive Brain Metastatic Localizations;PHARM RES-DORDR;2023